Services

THE
NUVISAN CONCEPT

The increasing complexity in the early development phase led to an increasing market demand for sophisticated CRO/CDMO partners.

The NUVISAN Concept

Connected services and support along the value chain
from research up to completions of phase II

API Synthesis

GMP
Method development & Validation

Lead Yes / No Go decision

In vitro / in vivo DMPK (Toxicology)

Formulation Development & Manufacturing

FIM Trial Design/ Drug Exposition

GLP / GCP Bioanalysis

A COMPLETE SERVICE PORTFOLIO ENABLES A PROCESS ORIENTED APPROACH

EU-Import & Packaging & Labeling

Post-clinical Service (Marketing Author.)

Medical Device & Reg. Cosmetic

SafetyLab Services

Clinical Conduct

Clinical Study Protocol Writing & CTA

Regulatory Consulting

NUVISAN provides all services from one single source
according from API Synthesis, Formulation Development
to Non-Clinical, Early Clinical, Pharmaceutical
as well as Bioanalytical Lab Services.

We recognized these trends early on and successfully positioned ourselves as Europe's only integrated full-service CRO provider.

Along the value chain, we offer a comprehensive portfolio of solutions from early development, Phase I to Phase IIa. Or in other words: from the molecule to the patient.

With such a comprehensive portfolio, you benefit from modular solutions of the highest quality that can be seamlessly combined.

At NUVISAN, these integrated services include the following business areas:
Pharmaceutical | Clinical | Non Clinical | Analytical.

Depending on your specific requirements and standard processes,
we work closely with you along the value chain and proactively
keep the next steps in mind during the course of the project.

Whereby you always decide which services you would like to use from us!

Passionate People for Perfect Projects.